Showing results (591-600 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|March 8, 2011
Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapyChristine Heinzle, Hedwig Sutterlüty, Michael Grusch, et al.Expert Opinion on Therapeutic Targets|March 11, 2011
Therapeutic targeting of tumor-stroma interactionsStephen Hiscox, Peter Barrett-Lee, Robert I NicholsonExpert Opinion on Therapeutic Targets|March 2, 2011
Targeting p27Kip1 protein: its relevance in the therapy of human cancerAdriana Borriello, Debora Bencivenga, Maria Criscuolo, et al.Expert Opinion on Therapeutic Targets|May 5, 2015
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?Demetrios Moris, Sotirios Georgopoulos, Evangelos Felekouras, et al.Expert Opinion on Therapeutic Targets|May 5, 2015
Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discoveryWilliam M PardridgeExpert Opinion on Therapeutic Targets|May 22, 2023
Toxoplasma gondii infection: novel emerging therapeutic targetsJoachim Müller, Andrew HemphillExpert Opinion on Therapeutic Targets|June 25, 2015
MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1Paula Mussnich, Roberta Rosa, Roberto Bianco, et al.Expert Opinion on Therapeutic Targets|July 3, 2015
Targeting α-synuclein as a therapeutic strategy for Parkinson's diseaseNada B Lawand, Nayef E Saadé, Omar M El-Agnaf, et al.Expert Opinion on Therapeutic Targets|July 14, 2015
Targeting the unfolded protein response for disease interventionAlexis Rivas, René Luis Vidal, Claudio HetzExpert Opinion on Therapeutic Targets|July 10, 2015
MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitorsRosamaria Pinto, Sabino Strippoli, Simona De Summa, et al.Pageof 232